Matthews Asia Dividend Active ETF ADVE 深 滬
已收盤 09-19 16:00:00 美东时间
35.0152
+0.799
+2.34%
華盛通- 最 高35.0152
- 今 開--
- 成交量 95股
- 最 低 35.0152
- 昨 收 34.2161
- 總市值 350.15万
- 52周最高 35.0152
- 市盈率 靜 --
- 換手率 0.10%
- 52周最低 28.0818
- 委 比 0.00%
- 總股本 10.00万
- 歷史最高 35.0152
- 量 比 0
- 振 幅 0.00%
- 歷史最低 28.0818
- 每 手 1
- 風險率 1.57%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Talicia® Launched in the United Arab Emirates
RedHill's Talicia, the first approved low-dose rifabutin-containing all-in-one combination treatment for H. pylori, is now available on prescription to treat adults with H. pylori infection ...
08-21 19:00
SILVERCORP COMPLETES ACQUISITION OF ADVENTUS
Trading Symbols: TSX/NYSE AMERICAN: SVM TSXV: ADZN / OTCQX: ADVZF VANCOUVER, BC and TORONTO, July 31, 2024 /PRNewswire/ - Silvercorp Metals Inc. ("Silvercorp") (TSX: SVM) (NYSE American: SVM...
08-01 03:24
波士顿科学二季度净销售额为41.20亿美元，增长14.5%
(医药健闻2024年7月26日讯)波士顿科学公司2024年第二季度的净销售额为41.20亿美元。与去年同期相比，公司基于财务报告的净销售额增长14.5%，运营净...
07-26 00:53
NUVEI OBTAINS FINAL COURT APPROVAL FOR GOING PRIVATE TRANSACTION WITH ADVENT
MONTREAL, June 20, 2024 /PRNewswire/ -- Nuvei Corporation ("Nuvei" or the "Company") (Nasdaq: NVEI)(TSX: NVEI), the Canadian fintech company, announced today that the Company has obtained a ...
06-21 00:30
Kroger Reports First Quarter 2024 Results and Reaffirms Guidance
First Quarter Highlights Identical Sales without fuel increased 0.5% Operating Profit of $1,294 million; EPS of $1.29 Adjusted FIFO Operating Profit of $1,499 million and Adjusted EPS of $1....
06-20 20:00
六月节假期碰上“三巫日”，本周美股波动或被放大
近日美国股市连番创下纪录高位，看起来势不可挡，但周三的六月节假日将把本周的交易分为两段，在这个因假期而缩短、交投可能较为淡静的一周，投资者的兴奋情绪对于股市的影响似要退居其次。
06-20 18:42
FOX AND THE TRADE DESK ANNOUNCE EXTENSIVE ADVERTISING INTEGRATIONS ACROSS FOX PORTFOLIO
Partnership Anchored Around Premium Content and Open Internet Industry Collaboration Expanded Integration of Unified ID 2.0 and OpenPath Through AdRise Commitment to Work Together Around Ide...
06-19 20:00
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
- Oral presentation highlighting final five-year efficacy data from the registrational Phase 2 trial of REZLIDHIA® (olutasidenib) in heavily pretreated patients with R/R mIDH1 AML, inclu...
06-14 15:05
Bell Media Announces 2024/25 Original Programming Slate
– 36 new English and French original programs are added to 62 previously announced titles, for a total slate of 98 – – Nearly three quarters of original programming hours come from beloved r...
06-06 19:00
Chimeric Advances AML Trial to New Cohort
Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeuti...
06-05 08:21
